Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents
Clinical trial NCT01783730 · COMPLETED
Trial details
- NCT number
- NCT01783730
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-02-01
- Primary completion
- 2015-09-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.